Login / Signup

The neuropathy in hereditary transthyretin amyloidosis: A narrative review.

Stefano TozzaDaniele SeveriEmanuele SpinaAniello IovinoFrancesco ArutaLucia RuggieroRaffaele DubbiosoRosa IodiceMaria NolanoFiore Manganelli
Published in: Journal of the peripheral nervous system : JPNS (2021)
Hereditary transthyretin amyloidosis (ATTRv) is a condition with adult onset, caused by mutation of the transthyretin (TTR) gene and characterized by extracellular deposition of amyloid fibrils in tissue, especially in the peripheral nervous system (PNS) and heart. PNS involvement leads to a rapidly progressive and disabling sensory-motor axonal neuropathy. Although awareness among neurologists increased in recent years thanks to new treatment options, ATTRv is frequently misdiagnosed, and thus a correct diagnosis can be delayed by several years. This review aims to draw the history and features of polyneuropathy in ATTRv based on pathological and electrophysiological correlates. We assessed original articles and case reports based on their relevance to ATTRv neuropathy and we included those appropriate for the scheme of this narrative review. Amyloid fibrils initially deposit in ganglia, causing an axonal neuropathy without amyloid deposits in distal segments (eg, sural nerve biopsy). Over time, amyloid fibrils spread along the nerves, leading to some demyelinating features in the context of severe axonal loss. This review highlights how the features of neuropathy change based on type of ATTRv (early vs late onset) and stage of disease.
Keyphrases
  • late onset
  • spinal cord injury
  • early onset
  • multiple sclerosis
  • heart failure
  • minimally invasive
  • atrial fibrillation
  • gene expression
  • transcription factor
  • dna methylation
  • fine needle aspiration